These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20148658)

  • 21. Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation.
    Saito M; Shiragami C; Shiraga F; Kano M; Iida T
    Am J Ophthalmol; 2010 Mar; 149(3):472-81.e1. PubMed ID: 20053392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal ranibizumab combined with verteporfin photodynamic therapy for treating polypoidal choroidal vasculopathy.
    Lee YH; Lee EK; Shin KS; Lee KM; Kim JY
    Retina; 2011; 31(7):1287-93. PubMed ID: 21386762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response.
    Schadlu R; Kymes SM; Apte RS
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1667-72. PubMed ID: 17583819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy.
    Lee MW; Yeo I; Wong D; Ang CL
    Eye (Lond); 2009 Jun; 23(6):1417-22. PubMed ID: 18756283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
    Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
    Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up.
    Leal S; Silva R; Figueira J; Cachulo ML; Pires I; de Abreu JR; Cunha-Vaz JG
    Retina; 2010 Sep; 30(8):1197-205. PubMed ID: 20827139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year results of photodynamic therapy with and without supplementary antivascular endothelial growth factor treatment for polypoidal choroidal vasculopathy.
    Saito M; Iida T; Kano M; Itagaki K
    Graefes Arch Clin Exp Ophthalmol; 2014 Feb; 252(2):227-35. PubMed ID: 23918094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolongation of choroidal hypofluorescence following combined verteporfin photodynamic therapy and intravitreal triamcinolone acetonide injection.
    Luttrull JK; Spink CJ
    Retina; 2007; 27(6):688-92. PubMed ID: 17621176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy.
    Wong IY; Shi X; Gangwani R; Zhao P; Iu LP; Li Q; Ng A; Li X
    BMC Ophthalmol; 2015 Jun; 15():66. PubMed ID: 26122636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone.
    Iwama D; Otani A; Sasahara M; Yodoi Y; Gotoh N; Tamura H; Tsujikawa A; Yoshimura N
    Br J Ophthalmol; 2008 Oct; 92(10):1352-6. PubMed ID: 18662914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparisons of outcomes with different intervals between adjunctive ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy.
    Sato T; Kishi S; Matsumoto H; Mukai R
    Am J Ophthalmol; 2013 Jul; 156(1):95-105.e1. PubMed ID: 23628354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-year outcome of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.
    Matsumiya W; Honda S; Otsuka K; Miki A; Nagai T; Imai H; Kusuhara S; Nakamura M
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):541-548. PubMed ID: 27687988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy: long-term results].
    Saito M; Nagayama D; Iida T
    Nippon Ganka Gakkai Zasshi; 2009 Aug; 113(8):792-9. PubMed ID: 19715154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.
    Silva RM; Figueira J; Cachulo ML; Duarte L; Faria de Abreu JR; Cunha-Vaz JG
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):973-9. PubMed ID: 15864616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Photodynamic therapy for polypoidal choroidal vasculopathy].
    You J; Guo X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):899-902. PubMed ID: 21946209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of photodynamic therapy in polypoidal choroidal vasculopathy.
    Akaza E; Yuzawa M; Matsumoto Y; Kashiwakura S; Fujita K; Mori R
    Jpn J Ophthalmol; 2007; 51(4):270-7. PubMed ID: 17660987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.
    Gomi F; Sawa M; Wakabayashi T; Sasamoto Y; Suzuki M; Tsujikawa M
    Am J Ophthalmol; 2010 Jul; 150(1):48-54.e1. PubMed ID: 20609707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen.
    Lai K; Li Y; Zhou L; Zhong X; Huang C; Xu F; Lu L; Ge J; Jin C
    BMC Ophthalmol; 2018 Jun; 18(1):144. PubMed ID: 29925341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.